Announcements Trials

Browse Landscape

Phase

Phase 2 11 Phase 1/2 1 Phase 1 1

Status

Completed 16 Terminated 8 Active not recruiting 8 Recruiting 7 Not yet recruiting 4 Withdrawn 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Cyclophosphamide 51 fludarabine 38 Injections 32 Gemcitabine 25 Paclitaxel 24 Cisplatin 22 Radiotherapy 19 toripalimab 18 pembrolizumab 18 Carboplatin 17 Capecitabine 17 Fluorouracil 15 Oxaliplatin 14 Nivolumab 14 Docetaxel 12 camrelizumab 11 apatinib 11 Temozolomide 11 Immunotherapy, Adoptive 11 Cetuximab 11 Bevacizumab 10 Irinotecan 9 Drug Therapy 9 sintilimab 8 Etoposide 8 aldesleukin 7 Taxes 7 Rituximab 7 Radiosurgery 7 Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unknown × daratumumab × Clear all

NCT02955810 2018-03-29

CyBorD-Dara

National University of Ireland, Galway, Ireland

Phase 1 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡